SUSQUEHANNA INTERNATIONAL GROUP, LLP - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 70 filers reported holding VIRACTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$23,678
+6.0%
16,793
+9.8%
0.00%
Q4 2022$22,338
-94.8%
15,300
-84.7%
0.00%
Q3 2022$427,000
-7.0%
99,900
-15.6%
0.00%
Q2 2022$459,000
-15.3%
118,400
+4.0%
0.00%
Q1 2022$542,000
+13.4%
113,800
-13.2%
0.00%
Q4 2021$478,000
+41.0%
131,116
+210.0%
0.00%
Q3 2021$339,000
-60.5%
42,300
-44.2%
0.00%
Q2 2021$859,000
-10.7%
75,803
-27.1%
0.00%
Q1 2021$962,000104,0110.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 689,709$1,096,6370.23%
Aisling Capital Management LP 288,571$458,8280.22%
BVF INC/IL 3,614,662$5,747,3130.21%
Rubric Capital Management LP 1,487,385$2,364,9420.06%
HAMILTON LANE ADVISORS LLC 35,791$570.02%
MAI Capital Management 379,468$603,3540.01%
Laurion Capital Management LP 698,000$1,109,8200.01%
TRUST CO OF TOLEDO NA /OH/ 28,000$44,5200.01%
RP Management, LLC 3,700$5,8830.01%
Jasper Ridge Partners, L.P. 92,939$147,7730.01%
View complete list of VIRACTA THERAPEUTICS INC shareholders